Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars
  • April 23, 2025

Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars

Medical device company Penumbra (NYSE:PEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.3% year on year to $324.1 million. The company expects the full year’s revenue to be around $1.35 billion, close to analysts’ estimates. Its non-GAAP profit of $0.83 per share was 24.4% above analysts’ consensus estimates.

Plexus (NASDAQ:PLXS) Reports Q1 In Line With Expectations
  • April 23, 2025

Plexus (NASDAQ:PLXS) Reports Q1 In Line With Expectations

Electronic manufacturing services company Plexus (NASDAQ:PLXS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.4% year on year to $980.2 million. The company expects next quarter’s revenue to be around $1.02 billion, close to analysts’ estimates. Its non-GAAP profit of $1.66 per share was 7.8% above analysts’ consensus estimates.